Vaccine for COVID-19
What do Covid-19 studies tell us?

In this interview with Dr. Satyajit Rath, we talk about the recent studies done on COVID-19 across the globe. We also look at the state of the vaccines under trial and the delivery mechanisms

Are we close to herd immunity?

In this interview with scientist Satyajit Rath, we talk about whether the world is any closer to reaching herd immunity. He also talks about the situation in India

Even with vaccines, it is a long and rocky road to immunity

Even if the major economies can solve their own problems of procuring the vaccines by jumping the queue with money or captive production capacities, what about the rest of the world?

COVID-19 vaccine: Emergency use authorization?

Immunologist Dr. Satyajit Rath talks about the decision of the US Food and Drug Administration to declare September 3 as the potential target date for the release of a vaccine for COVID-19

Cuba’s vaccine candidate “Sovereign” begins clinical trials today

Cuba’s vaccine candidate is the first from the Latin America and the Caribbean region and marks a continuation of its pioneering work in combating COVID-19 across the world

COVID 19: For how long do antibodies stay?

Dr. Satyajit Rath talks about the immunity developed in recovered COVID-19 patients and also the immunity that the potential vaccines can induce.

What do we know about the Russian COVID-19 vaccine?

Dr. Satyajit Rath talks to Peoples Dispatch about the recent announcement made by Russian president Vladimir Putin declaring that the country has developed a vaccine for COVID-19.

India’s COVID-19 strategy: A story of missteps

India has third highest number of COVID-19 cases in the world and is recording close to or over 50,000 cases a day. What explains this relentless surge in cases in the country?

COVID-19 vaccine may come, but what about equitable distribution?

With rich countries and big pharma companies getting proactive, there is widespread apprehension about access and price of the vaccine for countries that need it most.

US quitting WHO will hit global responses to pandemics, vaccine development

Newsclick’s Prabir Purkayastha talks about the US decision to leave the World Health Organization. He points out that this is yet another instance of US exceptionalism and describes how the country iis one of the largest beneficiaries of WHO’s vaccine program.

US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug

Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.

COVID-19: Dexamethasone provides some hope for severely ill

In a trial, Dexamethasone, an inexpensive and widely used corticosteroid, reduced deaths by one-third in ventilated patients and by one-fifth in patients receiving oxygen support

    × To Subscribe